Technical Analysis for TTNP - Titan Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 3.65 -1.39% -0.05
TTNP closed down 1.39 percent on Wednesday, November 20, 2024, on 1.27 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Low Weakness -1.39%
Gapped Down Weakness -1.39%
Lower Bollinger Band Touch Weakness -1.39%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Titan Pharmaceuticals, Inc. Description

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company's ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Organic Compounds Chemical Compounds Parkinson's Disease Opioids Schizophrenia Drug Delivery Chronic Condition Morphinans Drug Delivery Technology Treatment Of Schizophrenia Antipsychotic Atypical Antipsychotics Drug Rehabilitation Psychopathology Buprenorphine Fanapt Iloperidone

Is TTNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.8
52 Week Low 3.51
Average Volume 11,770
200-Day Moving Average 6.10
50-Day Moving Average 4.68
20-Day Moving Average 3.99
10-Day Moving Average 4.01
Average True Range 0.31
RSI (14) 31.51
ADX 16.91
+DI 23.31
-DI 26.83
Chandelier Exit (Long, 3 ATRs) 3.85
Chandelier Exit (Short, 3 ATRs) 4.45
Upper Bollinger Bands 4.39
Lower Bollinger Band 3.59
Percent B (%b) 0.08
BandWidth 20.23
MACD Line -0.25
MACD Signal Line -0.24
MACD Histogram -0.0063
Fundamentals Value
Market Cap 2.75 Million
Num Shares 753 Thousand
EPS -8.20
Price-to-Earnings (P/E) Ratio -0.45
Price-to-Sales 17.93
Price-to-Book 0.67
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.22
Resistance 3 (R3) 4.26 4.10 4.13
Resistance 2 (R2) 4.10 3.96 4.09 4.10
Resistance 1 (R1) 3.88 3.87 3.99 3.84 4.06
Pivot Point 3.72 3.72 3.78 3.70 3.72
Support 1 (S1) 3.50 3.58 3.61 3.46 3.24
Support 2 (S2) 3.34 3.49 3.32 3.20
Support 3 (S3) 3.11 3.34 3.17
Support 4 (S4) 3.08